190 related articles for article (PubMed ID: 19913091)
1. Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease.
Song N; Wang J; Jiang H; Xie J
Free Radic Biol Med; 2010 Jan; 48(2):332-41. PubMed ID: 19913091
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent.
Jiang H; Song N; Xu H; Zhang S; Wang J; Xie J
Cell Res; 2010 Mar; 20(3):345-56. PubMed ID: 20125122
[TBL] [Abstract][Full Text] [Related]
3. Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats.
Wang J; Jiang H; Xie JX
Eur J Neurosci; 2007 May; 25(9):2766-72. PubMed ID: 17561842
[TBL] [Abstract][Full Text] [Related]
4. Ferroportin1 and hephaestin overexpression attenuate iron-induced oxidative stress in MES23.5 dopaminergic cells.
Song N; Wang J; Jiang H; Xie J
J Cell Biochem; 2010 Aug; 110(5):1063-72. PubMed ID: 20564203
[TBL] [Abstract][Full Text] [Related]
5. Iron transport in Parkinson's disease.
Hirsch EC
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992
[TBL] [Abstract][Full Text] [Related]
6. Ndfip1 attenuated 6-OHDA-induced iron accumulation via regulating the degradation of DMT1.
Jia W; Xu H; Du X; Jiang H; Xie J
Neurobiol Aging; 2015 Feb; 36(2):1183-93. PubMed ID: 25467637
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells.
Zhang S; Wang J; Song N; Xie J; Jiang H
Neurobiol Aging; 2009 Sep; 30(9):1466-76. PubMed ID: 18191877
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
Ganser C; Papazoglou A; Just L; Nikkhah G
Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
[TBL] [Abstract][Full Text] [Related]
9. Does cellular iron dysregulation play a causative role in Parkinson's disease?
Kaur D; Andersen J
Ageing Res Rev; 2004 Jul; 3(3):327-43. PubMed ID: 15231240
[TBL] [Abstract][Full Text] [Related]
10. Over-expressed human divalent metal transporter 1 is involved in iron accumulation in MES23.5 cells.
Xu HM; Jiang H; Wang J; Luo B; Xie JX
Neurochem Int; 2008 May; 52(6):1044-51. PubMed ID: 18082289
[TBL] [Abstract][Full Text] [Related]
11. 6-Hydroxydopamine upregulates iron regulatory protein 1 by activating certain protein kinase C isoforms in the dopaminergic MES23.5 cell line.
Wang W; Song N; Zhang H; Xie J; Wang J
Int J Biochem Cell Biol; 2012 Nov; 44(11):1987-92. PubMed ID: 22846799
[TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of iron concentration and expression of ferroportin 1 in the cortex and hippocampus of rats induced by cerebral ischemia.
Li L; Li YW; Zhao JY; Liu YZ; Holscher C
J Clin Neurosci; 2009 Nov; 16(11):1466-72. PubMed ID: 19766498
[TBL] [Abstract][Full Text] [Related]
14. Ceruloplasmin is Involved in the Nigral Iron Accumulation of 6-OHDA-Lesioned Rats.
Wang J; Bi M; Xie J
Cell Mol Neurobiol; 2015 Jul; 35(5):661-8. PubMed ID: 25656940
[TBL] [Abstract][Full Text] [Related]
15. Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum.
Galy B; Ferring-Appel D; Kaden S; Gröne HJ; Hentze MW
Cell Metab; 2008 Jan; 7(1):79-85. PubMed ID: 18177727
[TBL] [Abstract][Full Text] [Related]
16. Divalent metal transporter, iron, and Parkinson's disease: a pathological relationship.
Lee HP; Zhu X; Liu G; Chen SG; Perry G; Smith MA; Lee HG
Cell Res; 2010 Apr; 20(4):397-9. PubMed ID: 20357807
[No Abstract] [Full Text] [Related]
17. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease.
Shim JS; Kim HG; Ju MS; Choi JG; Jeong SY; Oh MS
J Ethnopharmacol; 2009 Nov; 126(2):361-5. PubMed ID: 19703534
[TBL] [Abstract][Full Text] [Related]
18. Adaptive changes of duodenal iron transport proteins in celiac disease.
Barisani D; Parafioriti A; Bardella MT; Zoller H; Conte D; Armiraglio E; Trovato C; Koch RO; Weiss G
Physiol Genomics; 2004 May; 17(3):316-25. PubMed ID: 15054143
[TBL] [Abstract][Full Text] [Related]
19. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine.
Rodriguez-Blanco J; Martín V; Herrera F; García-Santos G; Antolín I; Rodriguez C
J Neurochem; 2008 Oct; 107(1):127-40. PubMed ID: 18665912
[TBL] [Abstract][Full Text] [Related]
20. Rg1 protects iron-induced neurotoxicity through antioxidant and iron regulatory proteins in 6-OHDA-treated MES23.5 cells.
Xu H; Jiang H; Wang J; Xie J
J Cell Biochem; 2010 Dec; 111(6):1537-45. PubMed ID: 20872781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
